汉防己甲素对兔角膜基质细胞和上皮细胞抑制作用的对比研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的
     比较汉防己甲素对离体兔角膜基质细胞和上皮细胞的抑制作用,并与艾氟龙对比,然后初步探讨其对角膜基质细胞和上皮细胞的作用机理,一方面了解汉防己甲素对兔角膜上皮细胞和基质细胞抑制作用是否存在差异,另一方面了解其与艾氟龙的药效作用是否存在差异,以寻求一种能替代皮质类固醇用于防治屈光术后Haze形成的药效强、副作用低的药物。
     方法
     1、选用原代及传代兔角膜基质细胞,实验组加入含不同质量浓度汉防己甲素(1 ~ 10μg/ml)的培养液,对照组加入等量空白培养液,同时用不同质量浓度艾氟龙(5 ~ 90μg/ml)作比较;选用原代及传代兔角膜上皮细胞,实验组加入含不同质量浓度汉防己甲素(1 ~ 10μg/ml)的培养液,对照组加入等量空白培养液,同时用不同质量浓度艾氟龙(5 ~ 130μg/ml)作比较。分别培养24、48、72 h后,采用MTT比色法检测药物对细胞增殖的抑制作用,计算出抑制率和IC50,并对其进行比较。2、将汉防己甲素作用于基质细胞和上皮细胞48h后,运用流式细胞仪测定细胞周期和细胞凋亡率的变化。3、汉防己甲素作用于基质细胞和上皮细胞48h后,用免疫细胞化学法检测基质细胞和上皮细胞表达P21和E2F1的情况。
     结果
     1、汉防己甲素在角膜基质细胞各时间段不同浓度组,均能明显抑制基质细胞的增殖,其24、48、72 h的IC50分别为4.14、3.42和2.84μg/ml,并具有明显的时间剂量-效应依赖关系。汉防己甲素在角膜上皮细胞各时间段不同浓度组,均能抑制上皮细胞的增殖,其24、48、72 h的IC50分别为7.38、4.14和3.37μg/ml,也具有明显的时间剂量-效应依赖关系;汉防己甲素作用于基质细胞各时间点IC50均低于上皮细胞。艾氟龙在各时间段不同浓度组,对角膜基质细胞和上皮细胞生长都具有抑制作用,其对角膜基质细胞和上皮细胞各时间点IC50分别为52.81、36.27、33.16μg/ml和69.19、42.01、35.83μg/ml;汉防己甲素作用于基质细胞和上皮细胞各时间点IC50均低于艾氟龙。2、汉防己甲素作用后,流式细胞仪结果显示角膜基质细胞和上皮细胞G0/G1期细胞均增加,并可见到细胞凋亡峰和凋亡率的升高。3、免疫细胞化学结果显示,角膜基质细胞和上皮细胞对照组和实验组均有P21蛋白和E2F1蛋白的表达,但两种细胞实验组中P21蛋白的表达均增强,E2F1蛋白的表达均减弱。
     结论
     1、汉防己甲素对角膜基质细胞和上皮细胞的增生均有抑制作用,其抑制作用均强于艾氟龙,且汉防己甲素对基质细胞的抑制作用强于对上皮细胞的抑制作用。
     2、汉防己甲素可能通过使细胞周期停滞在G0/G1期和诱导细胞凋亡而发挥其对角膜基质细胞和上皮细胞的抗增殖作用。3、汉防己甲素可能是通过调节P21、E2F1使角膜基质细胞和上皮细胞周期停滞在G0/G1期。
Objective To investigate the effect of tetrandrine on inhibition of RCSCs and RCECs and to explore the mechanism. To try hard to search out a strong effect and weak side effect drug which can replace corticosteroid to treat haze after refractive surgery.
     Methods 1. The primary cultured and subcultured RCSCs were exposed to different concentrations of tetrandrine(1~10μg/ml) and fluorometholone(5~90μg/ml) in experimental groups and to blank culture media in contrast group. The primary cultured and subcultured RCECs were exposed to different concentrations of tetrandrine(1~10μg/ml) and fluorometholone(5~130μg/ml) in experimental groups and to blank culture media in contrast group. Then RCSCs and RCECs were cultivated for 24 h、48 h、72h. The inhibitive characteristics to the cells’proliferation were measured with methyl thiazolyl tetrazolium (MTT) assay. The antiproliferative rate of cells and the IC50 were calculated and compared. 2. After the effect of tetrandrine on RCSCs and RCECs for 48h, the changes of cells cycles and the apoptosis rate were observed with flow cytometer (FCM). 3. After the effect of tetrandrine on RCSCs and RCECs for 48h, the changes of the expression of P21 and E2F1 were measured by immunocytochemistry.
     Results 1. After the treatment of tetrandrine , RCSCs showed the marked inhibition in 24h、48h、72h and showed marked time-dosage -effect dependence. Its IC50 of three time-point were 4.14、3.42 and 2.84μg/ml in RCSCs. After the treatment of tetrandrine , RCECs showed the inhibition in 24h、48h、72h and showed marked time-dosage -effect dependence. Its IC50 of three time-point were 7.38、4.14 and 3.37μg/ml in RCECs. The IC50 of tetrandrine at each time point in RCSCs was lower than that in RCECs. After the treatment of fluorometholone, RCSCs and RCECs showed the inhibition in 24h、48h、72h and showed marked time-dosage -effect dependence. The IC50 of fluorometholone at each time point in RCSCs and RCECs were 52.81、36.27、33.16μg/ml and 69.19、42.01、35.83μg/ml. The IC50 of tetrandrine at each time point in RCSCs and RCECs were lower than that of fluorometholone. 2. After the treatment of tetrandrine, FCM result showed that the percentage of RCSCs and RCECs in G0/G1 phase increased obviously and the apoptosis cusp and rate also increased. 3. Immunocytochemistry showed increased expression of P21 and decreased expression of E2F1 in RCSCs and RCECs after the treatment of tetrandrine.
     Conclusion 1. Tetrandrine has inhibitory effect on the proliferation of RCSCs and RCECs. The effect is more dominant in comparison with fluorometholone. The inhibitory effect of tetrandrine on RCSCs is stronger than that on RCECs . 2. Tetrandrine may exert its antiproliferative effect on RCSCs and RCECs by ceasing cell cycle with P21 and E2F1 and by inducing cell apotosis.
引文
[1]汪芳润.近视眼研究的现状与存在问题[J].中华眼科杂志,2003,39(6):381.
    [2]郑曰忠.近视眼的流行病学[J].眼科,2001,10(5):301.
    [3] Lohmann CP, Gartry DS, Muir MK, et al. Corneal haze after excimer laser refractive surgery: objective measurements and functional implications. Eur J Ophthalmol, 1991,1(4):173-80
    [4]齐虹,朱秀安.准分子激光屈光性角膜切削术后角膜雾状混浊发生机制的研究.解剖学报,2002;33(1):78~83
    [5] Fitzsimmons TD, Fagerholm P, Harfstrand A, et al. Hyaluronic acid in the rabbit cornea after excimer laser superficial keratectomy. Invest Ophthalmol Vis Sci, 1992, 33(11):3011-6
    [6]梁健,庞玉生.肝纤维化发病机理的研究进展.广西医学,2002;24(5):650~652
    [7] Wilson SE, Kim WJ.Keratocyte apoptosis:implications on corneal wound healing,tissue organization and disease[J].Invest Ophthalmol Vis Sci,1998,39(2):220-226
    [8]尹德海,郑法雷.汉防己甲素的研究概况及其应用前景[J].世界医学杂志,2002,6(9):64-66
    [9]李万同,罗力生,柳大烈.汉防己甲素对增生性瘢痕中成纤维细胞增殖和活力的影响.现代康复,2000,1:66~67
    [10]秦力维,郭建巍,金婉容.汉防己甲素及地塞米松对免结膜成纤维细胞增殖的抑制作用.眼科新进展,2002,5:318~320
    [11]孙自勤,王要军,权启镇.汉防己甲素与秋水仙碱抗肝纤维化作用的比较[J].中国药理学通报,1996,12(4):345
    [12]屈隧林.汉防己甲素、川芍嗓和苦杏仁贰对人肾成纤维细胞的影响[J].中华肾脏病杂志,2000,16(3):18
    [13] Chang DM, Chang WY, Kuo SY. The effects of traditional antirheumatic herbal medicines on immune response cells. J Rheumatol, 1997;24:436~441
    [14]高吉莲,刘灿兰,赵琳娜等.汉防已甲素对肾病综合征大鼠肾转化生长因子β1影响的观察[J].齐齐哈尔医学院学报,2001,3:241~242
    [15]牟章兵,杜之渝,晏丕松.汉防己甲素对离体兔角膜基质细胞抑制机制的实验研究[J].眼科研究,2007,25(1):29-32
    [16]陶丹,杜之渝.汉防己甲素对PRK术后Ⅲ型胶原的影响[J].眼科研究,2008, 26(5):359-361
    [17]陶丹,杜之渝.汉防己甲素对PRK术后纤维连接蛋白的影响[J].眼科新进展,2008,28(10):746-748
    [18]赵武校,杜之渝,黄正等.汉防己甲素抑制兔Epi-LASIK术后上皮下雾状混浊形成的组织病理研究[J].中国实用眼科杂志,2007,25(9):1045-1050
    [19]车艺,汤为学,郑维萍.中效原理在顺铂、5-氟脲嘧啶、长春新碱对人卵巢癌细胞株(SKOV3)相互作用中的应用[J].实用妇产科杂志,2002,18(6):364-365.
    [20] Nasmyth K and Hunt T. Dams and sluices [J]. Nature, 1993, 366:634-635
    [21]荣蓓,晏晓明,吴静安.人角膜基质细胞中cyclin-CDK-CKI网络成员的表达[J].中国实用眼科杂志,2001,19(8):584-587
    [22] MCKENZIE P P,DANKS M K,KRIWACKI R W,et al. P21Waf11/Cip1 dysfunction in neuroblastoma : a novel mechanism of attenuating G0-G1 cell cycle arrest[J]. Cancer Res,2003,63(13):3840-3844.
    [23] Michalides RJ.Cell cycle regulators:mechanisms and their role in aetiology,prognosis and treatment of cancer(J].J Clin Pathol,1999,52:555.
    [24] Kowalid TF,DeGregore J,Schwarz JK,et al. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis[J]. J Virol,1995,69(4):2491-2500.
    [25] Putzer BM. E2F1 death pathways as targets for cancer therapy[J]. J Cell Mol Med JT-Journal of cellular and molecular medicine,2007,11(2):239-251.
    [26] Meng LH, Zhang H, Hayward L, et al. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Ci- p1. Cancer Res, 2004,64(24):9086~92
    [27] Short AD, Bian J. Intracellular Ca2+ pool content is linked to control of cellgrowth[J]. Proc Natl Acad Sci USA, 1993,90(11):4 986
    [28] Mastrangelo AJ, Betenbaugh HJ. Apoptosis: new methods for improving protein expression systems. Trends-Biotechnol, 1998,16(2):88
    [1] Wilson SE, Kim WJ.Keratocyte apoptosis:implications on corneal wound healing,tissue organization and disease[J].Invest Ophthalmol VisSci,1998,39(2):220-226
    [2]赵愈敏,袁南荣,袁志兰等.丝裂霉素C与地塞米松治疗PRK后角膜上皮下雾状混浊的对比实验研究[J].眼科新进展,2002,22(2):88-90.
    [3] Weber BA.Gan L.Fagerholm PP.Short-term impact of corticosteroids on hyaluronan and epithelial hyperplasia in the rabbit cornea after photo- refractive keratectomy [J].Cornea ,200l,20:32l-324.
    [4] Tani E,Katakami C,Negi A. Effects of various eye drops on corneal wound healing after superficial keratectomy in rabbits[J].Jpn J Ophthalmol,2002,46(5):488-495
    [5] Vetrugno M,Maino A,Quaranta GM,et al.The effect of early steroid treatment after PRK on clinical and refractive outcomes [J]. Acta Ophthalmol Scand,2001,79(1):23-27.
    [6] Kaji Y,Amano S,Oshika T,et al.Effect of anti-inflammatory agents on corneal wound-healing process after surface excimer laser keratectomy[J].J Cataract Refract Surg,2000,26 (3):426-431
    [7]贺瑞,刘克兰,米琳等.双氯酚酸钠对准分子激光角膜切削术后角膜上皮下混浊的影响[J].眼视光学杂志,2001,3(2):78-80
    [8]尹德海,郑法雷.汉防己甲素的研究概况及其应用前景[J].世界医学杂志,2002,6(9):64-66
    [9]梁健,庞玉生.肝纤维化发病机理的研究进展[J].广西医学,2002;24(5):650-652
    [10]牟章兵,杜之渝,晏丕松.汉防己甲素对离体兔角膜基质细胞抑制机制的实验研究[J].眼科研究,2007,25(1):29-32
    [11]陶丹,杜之渝.汉防己甲素对PRK术后Ⅲ型胶原的影响[J].眼科研究,2008, 26(5):359-361
    [12]陶丹,杜之渝.汉防己甲素对PRK术后纤维连接蛋白的影响[J].眼科新进展,2008,28(10):746-748
    [13]赵武校,杜之渝,黄正等.汉防己甲素抑制兔Epi-LASIK术后上皮下雾状混浊形成的组织病理研究[J].中国实用眼科杂志,2007,25(9):1045-1050
    [14] Kim T1,Lee SY,Pak JH,et al. Mitomycin C,ceramide,and 5-fluorouracil inhibit corneal haze and apoptosis after PRK[J].Cornea ,2006,25(1):55-60
    [15] Bedei A,Marabotti A,Giannecchini I,et al.PRK in high myopic defects with or without intraoperative mitomycin C:1-year results[J].Eur J Ophthalmol,2006,16(2):229-234
    [16]王莉,张明昌,王勇等.高三尖杉酯碱对PRK后角膜浑浊的影响[J].眼外伤职业眼病杂志,2004,26(5):289-292
    [17] Bergman RH,Spigrman AV.The role of fibroblast inhibitors on corneal healing following photorefractive keratectomy with 193 nm excimer laser in rabbits[J].Ophthalmol Surg,1994,25:l70-174
    [18]李红,郭玉,廖端芳等.甘草次酸抑制兔准分子激光角膜切削术后角膜上皮下混浊的作用[J].中国药理学通报,2004,20(3):279-282
    [19]刘怡.麝珠明目滴眼液对PRK术后角膜上皮下混浊并发激素性高眼压的影响[J].中国实用眼科杂志,2003,21(5):386-387
    [20] Kuo IC,Seitz B,LaBreel,et a1.Can Zinc prevent apoptosis of anterior keratocytes after superficial keratectomy[J].Cornea,1997,16(5):550-555.
    [21]康风英,陶靖,李前进等.准分子激光屈光性角膜切削术后免角膜基质细胞凋亡及其防治的研究[J].中华眼科杂志,2002,38(7):433-437
    [22] Baldwin HC.Marshall J.Growth factors in corneal wound healing following refractive surgery[J].Acta Ophthalmol,2002,80(3):238-247
    [23] Lee JB,Seo KY,Lee K.Non-tuberculous mvcobacterial keratrtis at the interface after laser in situ keratomileusis[J].J Refract Surg,2002,18(1):81-85
    [24] Thorn SB,Myers JS,Rapuano CJ,et a1.Effect of topical antitransforming growth factor-beta on corneal stromal haze after photorefractive keratectomy in rabbits[J].JCataract Refract Surg ,1997,23:1324-1330.
    [25]张明昌,李斌,胡燕华等.干扰素a一2b治疗准分子激光角膜切削术后角膜上皮下混浊的实验研究[J].中华眼科杂志,2003,39(3):146-149

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700